Posts

Showing posts with the label vaccine

Chubb, Marsh partner on vaccine cover for lower-income countries

Chubb Ltd. and Marsh LLC worked with the World Health Organization and Gavi, the Vaccine Alliance, to provide $ 150 million in insurance coverage for a program to compensate certain people for serious adverse events caused by vaccines. The no-fault compensation program provides eligible individuals in 92 lower-income countries with an opportunity to receive compensation for adverse events related to vaccines distributed under the COVAX vaccination initiative through June 30, 2022, Chubb and Marsh said in a statement on June 30, 2022 Thursday with. Marsh led the global placement of the coverage while Chubb is the primary insurer, backed by 10 other insurers in the US, UK, Germany, Ireland, Switzerland and Bermuda. "The scale of the COVID-19 pandemic requires everyone from governments and health officials to the private sector to contribute their skills, abilities and resources to help end this crisis," said Evan Greenberg, Chairman and CEO by Chubb. said in the stateme...

Marsh, Chubb collaborate on COVID-19 vaccine program

  COVAX is designed to expedite the development and manufacture of COVID-19 vaccines and to ensure their fair and equitable distribution in all countries of the world. The Chubb-Marsh collaboration will provide up to $ 150 million in insurance to the COVAX No-Fault Compensation program to cover compensation for eligible individuals in the 92 lower-income countries and economies collectively known as Gavi COVAX Advance Market Commitment (Gavi COVAX Advance Market Commitment). AMC) eligible economies. Insurance broker Marsh directed the worldwide placement of the cover. Chubb is the main insurer, backed by 10 other insurers in the US, UK, Germany, Ireland, Switzerland and Bermuda. The delivery of COVID-19 vaccines in 2021 will be the largest and fastest proliferation of novel vaccines in the world in history. COVAX aims to deliver up to two billion doses by the end of the year, including up to 1.7 billion doses to the 92 AMC-eligible countries and economies. "Chubb is excited t...